1. Home
  2. CASI vs SAGT Comparison

CASI vs SAGT Comparison

Compare CASI & SAGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASI
  • SAGT
  • Stock Information
  • Founded
  • CASI 1991
  • SAGT 2018
  • Country
  • CASI China
  • SAGT Malaysia
  • Employees
  • CASI N/A
  • SAGT N/A
  • Industry
  • CASI Biotechnology: Pharmaceutical Preparations
  • SAGT
  • Sector
  • CASI Health Care
  • SAGT
  • Exchange
  • CASI Nasdaq
  • SAGT NYSE
  • Market Cap
  • CASI 20.5M
  • SAGT 22.2M
  • IPO Year
  • CASI 1996
  • SAGT 2025
  • Fundamental
  • Price
  • CASI $1.29
  • SAGT $1.92
  • Analyst Decision
  • CASI Strong Buy
  • SAGT
  • Analyst Count
  • CASI 1
  • SAGT 0
  • Target Price
  • CASI $4.00
  • SAGT N/A
  • AVG Volume (30 Days)
  • CASI 79.1K
  • SAGT 239.6K
  • Earning Date
  • CASI 08-15-2025
  • SAGT 01-01-0001
  • Dividend Yield
  • CASI N/A
  • SAGT N/A
  • EPS Growth
  • CASI N/A
  • SAGT 63.63
  • EPS
  • CASI N/A
  • SAGT 0.26
  • Revenue
  • CASI $31,368,000.00
  • SAGT $19,041,727.00
  • Revenue This Year
  • CASI N/A
  • SAGT N/A
  • Revenue Next Year
  • CASI N/A
  • SAGT N/A
  • P/E Ratio
  • CASI N/A
  • SAGT $7.35
  • Revenue Growth
  • CASI 8.39
  • SAGT 91.75
  • 52 Week Low
  • CASI $1.09
  • SAGT $1.50
  • 52 Week High
  • CASI $7.67
  • SAGT $6.24
  • Technical
  • Relative Strength Index (RSI)
  • CASI 42.66
  • SAGT N/A
  • Support Level
  • CASI $1.21
  • SAGT N/A
  • Resistance Level
  • CASI $1.77
  • SAGT N/A
  • Average True Range (ATR)
  • CASI 0.13
  • SAGT 0.00
  • MACD
  • CASI 0.01
  • SAGT 0.00
  • Stochastic Oscillator
  • CASI 14.29
  • SAGT 0.00

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

About SAGT SAGTEC GLOBAL LIMITED

Sagtec Global Ltd is principally involved in the provision of customizable software solutions encompassing several types of software such as a smart ordering system, Speed +, which is a smart solutions application software for the food and beverage industry. The Speed+ software is installed onto its existing Point of Sale (POS) machines, which are sourced from third-party suppliers. The company operates SaaS business, Software Customisation, Data analysis and Hosting Services, Outright Purchase, and Others.

Share on Social Networks: